A detailed history of Nordea Investment Management Ab transactions in Illumina, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 11,457 shares of ILMN stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,457
Previous 11,636 1.54%
Holding current value
$1.51 Million
Previous $1.52 Million 0.86%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

SELL
$128.99 - $155.15 $23,089 - $27,771
-179 Reduced 1.54%
11,457 $1.53 Million
Q3 2024

Nov 05, 2024

SELL
$105.28 - $135.9 $284,782 - $367,609
-2,705 Reduced 18.86%
11,636 $1.52 Million
Q2 2024

Aug 08, 2024

SELL
$101.05 - $133.57 $4,143 - $5,476
-41 Reduced 0.29%
14,341 $1.5 Million
Q1 2024

May 02, 2024

BUY
$127.73 - $147.2 $100,140 - $115,404
784 Added 5.77%
14,382 $1.97 Million
Q4 2023

Jan 10, 2024

BUY
$92.79 - $142.53 $23,011 - $35,347
248 Added 1.86%
13,598 $1.89 Million
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $347,799 - $519,203
-2,698 Reduced 16.81%
13,350 $1.83 Million
Q2 2023

Jul 07, 2023

SELL
$183.43 - $232.67 $577,804 - $732,910
-3,150 Reduced 16.41%
16,048 $3.01 Million
Q1 2023

Apr 19, 2023

SELL
$193.75 - $232.55 $364,250 - $437,194
-1,880 Reduced 8.92%
19,198 $4.46 Million
Q4 2022

Feb 08, 2023

SELL
$187.24 - $242.74 $155,409 - $201,474
-830 Reduced 3.79%
21,078 $4.26 Million
Q3 2022

Oct 19, 2022

SELL
$177.23 - $227.44 $2.45 Million - $3.14 Million
-13,824 Reduced 38.69%
21,908 $4.09 Million
Q2 2022

Aug 09, 2022

SELL
$181.58 - $368.0 $1.18 Million - $2.38 Million
-6,471 Reduced 15.33%
35,732 $6.49 Million
Q1 2022

Apr 11, 2022

SELL
$303.87 - $423.8 $7.76 Million - $10.8 Million
-25,552 Reduced 37.71%
42,203 $14.9 Million
Q4 2021

Jan 20, 2022

SELL
$347.28 - $421.83 $351,447 - $426,891
-1,012 Reduced 1.47%
67,755 $26 Million
Q3 2021

Nov 01, 2021

BUY
$405.61 - $524.84 $28.1 Million - $36.3 Million
69,257 Added 101.44%
137,534 $55.8 Million
Q3 2021

Nov 01, 2021

SELL
$405.61 - $524.84 $27.9 Million - $36.1 Million
-68,767 Reduced 50.0%
68,767 $28.6 Million
Q2 2021

Jul 16, 2021

BUY
$372.84 - $481.5 $10.5 Million - $13.5 Million
28,030 Added 69.64%
68,277 $32.3 Million
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $755,797 - $1.06 Million
2,092 Added 5.48%
40,247 $15.5 Million
Q4 2020

Feb 12, 2021

SELL
$292.7 - $370.96 $23 Million - $29.1 Million
-78,453 Reduced 67.28%
38,155 $14.1 Million
Q3 2020

Nov 09, 2020

SELL
$268.51 - $400.74 $26.9 Million - $40.1 Million
-100,072 Reduced 46.18%
116,608 $35.9 Million
Q2 2020

Aug 13, 2020

BUY
$256.46 - $373.01 $27 Million - $39.2 Million
105,153 Added 94.28%
216,680 $80.2 Million
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $2.06 Million - $3.3 Million
-9,831 Reduced 8.1%
111,527 $30.2 Million
Q4 2019

Feb 11, 2020

BUY
$288.29 - $335.49 $590,994 - $687,754
2,050 Added 1.72%
121,358 $40 Million
Q3 2019

Nov 13, 2019

SELL
$266.84 - $378.23 $5.46 Million - $7.75 Million
-20,477 Reduced 14.65%
119,308 $36.2 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $2.96 Million - $3.63 Million
9,860 Added 7.59%
139,785 $51.5 Million
Q1 2019

May 20, 2019

BUY
$272.57 - $321.18 $18.1 Million - $21.3 Million
66,471 Added 104.75%
129,925 $40.4 Million
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $15.1 Million - $20.3 Million
55,415 Added 689.33%
63,454 $19 Million
Q3 2018

Nov 14, 2018

BUY
$279.04 - $367.06 $200,350 - $263,549
718 Added 9.81%
8,039 $2.95 Million
Q1 2018

May 14, 2018

BUY
$209.54 - $253.91 $63,700 - $77,188
304 Added 4.33%
7,321 $1.73 Million
Q4 2017

Feb 12, 2018

SELL
$202.23 - $230.03 $11,931 - $13,571
-59 Reduced 0.83%
7,017 $1.53 Million
Q3 2017

Nov 09, 2017

BUY
$172.3 - $213.93 $1.22 Million - $1.51 Million
7,076
7,076 $1.41 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.